Literature DB >> 14769325

Elliptical rotation flap for pilonidal sinus.

Gürel Neşşar1, Cüneyt Kayaalp, Canbek Seven.   

Abstract

BACKGROUND: The treatment of the symptomatic pilonidal sinus is surgical with one of the most extensive being excision of the diseased tissue down to the sacral fascia. The closure of the defect is the matter of debate. An elliptical rotation flap has been used for pilonidal sinus treatment with no recurrence rate.
METHODS: From April 1996 to June 2001, 20 patients were treated with this technique. The surgical procedure is a vertical elliptical excision of the diseased tissue and an elliptical cutaneous rotation flap to close the defect.
RESULTS: Twenty patients underwent with this technique, mean age 23.4 years (range 18 to 34). Mean follow-up was 42 months. All patients were discharged on the first postoperative day. Primary healing was achieved in all of the patients in 2 weeks. No recurrence was observed.
CONCLUSIONS: Elliptical rotation flap is recommended for patients selected for defect closure. It offers improved patient comfort, shorter hospital stay, and no recurrence rate.

Entities:  

Mesh:

Year:  2004        PMID: 14769325     DOI: 10.1016/j.amjsurg.2003.11.012

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  16 in total

1.  Effectiveness of a drain in surgical treatment of sacrococcygeal pilonidal disease. Results of a randomized and controlled clinical trial on 803 consecutive patients.

Authors:  Marco Milone; Milone Marco; Mario Musella; Musella Mario; Giuseppe Salvatore; Salvatore Giuseppe; Maddalena Leongito; Leongito Maddalena; Francesco Milone; Milone Francesco
Journal:  Int J Colorectal Dis       Date:  2011-05-15       Impact factor: 2.571

Review 2.  German national guideline on the management of pilonidal disease.

Authors:  I Iesalnieks; A Ommer; S Petersen; D Doll; A Herold
Journal:  Langenbecks Arch Surg       Date:  2016-06-16       Impact factor: 3.445

3.  Is the lateralization distance important in terms in patients undergoing the modified Limberg flap procedure for treatment of pilonidal sinus?

Authors:  B R Karakaş; A Aslaner; U R Gündüz; H Çalış; A N Öngen; O Z Öner; N Bülbüller
Journal:  Tech Coloproctol       Date:  2014-12-02       Impact factor: 3.781

4.  The modified gluteal sliding plication closure in the treatment of chronic pilonidal sinus.

Authors:  Wael M El-Shaer
Journal:  Int J Colorectal Dis       Date:  2010-03-10       Impact factor: 2.571

5.  Day-care surgery for pilonidal sinus.

Authors:  A K M Abdul-Ghani; A N Abdul-Ghani; C L Ingham Clark
Journal:  Ann R Coll Surg Engl       Date:  2006-11       Impact factor: 1.891

6.  Fibrin glue in the treatment for pilonidal sinus: high patient satisfaction and rapid return to normal activities.

Authors:  E Elsey; J N Lund
Journal:  Tech Coloproctol       Date:  2012-12-06       Impact factor: 3.781

7.  Pilonidal sinus surgery: could we predict postoperative complications?

Authors:  Marco Milone; Matteo Nd Di Minno; Paolo Bianco; Guido Coretti; Mario Musella; Francesco Milone
Journal:  Int Wound J       Date:  2014-06-03       Impact factor: 3.315

8.  V-y advancement flap technique in resurfacing postexcisional defect in cases with pilonidal sinus disease-study of 25 cases.

Authors:  Parag Sahasrabudhe; Nikhil Panse; Chandrashekhar Waghmare; Pankaj Waykole
Journal:  Indian J Surg       Date:  2012-01-19       Impact factor: 0.656

9.  A New Oval Advancement Flap Design for Reconstruction of Pilonidal Sinus Defect.

Authors:  Enver Arpaci; Serdar Altun; Erkan Orhan; Atilla Eyuboglu; Nilgun Markal Ertas
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

10.  Randomised clinical trial of pilonidal sinus operations performed in the prone position under spinal anaesthesia with hyperbaric bupivacaine 0.5 % versus total intravenous anaesthesia.

Authors:  Marc D Schmittner; Sven Dieterich; Volker Gebhardt; Christel Weiss; Marc A Burmeister; Dieter G Bussen; Tim Viergutz
Journal:  Int J Colorectal Dis       Date:  2012-11-30       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.